Literature DB >> 22215745

Health-related quality of life among 5-year survivors of esophageal cancer surgery: a prospective population-based study.

Maryam Derogar1, Pernilla Lagergren.   

Abstract

PURPOSE: To clarify whether health-related quality of life (HRQL) can be restored in 5-year survivors of esophageal cancer surgery. PATIENTS AND METHODS: The nationwide Swedish prospective and population-based cohort for this study consisted of patients with esophageal cancer who were treated surgically between 2001 and 2005 and were alive 5 years after surgery. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) and EORTC QLQ-OES18 (the disease site-specific module for esophageal cancer) were used to assess HRQL 6 months, 3 years, and 5 years postoperatively. Paired t tests were used to evaluate changes in HRQL over time. Patients' HRQL was classified as improved, stable, or deteriorated. Multivariable linear regression was used to calculate mean score difference in HRQL with 95% CIs between patients and a background population according to HRQL category.
RESULTS: Among 153 eligible patients alive after 5 years, 117 (76%) answered all HRQL assessments. Among a random sample of 6,969 Swedish adults representing the corresponding background population, 4,910 (70.5%) participated. For most patients, HRQL remained stable or improved over time, and their HRQL was comparable to that of the background population. Patients who deteriorated over time reported large and clinically significant mean score differences for all measures. For example, 5 years after surgery, physical function was stable or improved in 86% of patients and their mean score (87) was similar to that of the background population (88), but the 14% who deteriorated had a substantially lower mean score of 56.
CONCLUSION: HRQL recovers to a level comparable to that in the background population in most patients who survive 5 years after esophagectomy for cancer, although a subgroup of patients has substantially worse HRQL.

Entities:  

Mesh:

Year:  2012        PMID: 22215745     DOI: 10.1200/JCO.2011.38.9791

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  37 in total

1.  Health-related quality of life after Ivor Lewis esophagectomy.

Authors:  Christian A Gutschow; Arnulf H Hölscher; Jessica Leers; Hans Fuchs; Marc Bludau; Klaus L Prenzel; E Bollschweiler; Wolfgang Schröder
Journal:  Langenbecks Arch Surg       Date:  2012-06-04       Impact factor: 3.445

Review 2.  Minimally invasive esophagectomy for Barrett's adenocarcinoma.

Authors:  Emanuele Asti; Daniele Bernardi; Marco Sozzi; Luigi Bonavina
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-16

3.  Locally advanced esophageal cancer: What becomes of 5-year survivors?

Authors:  Galal Ghaly; Mohamed Kamel; Abu Nasar; Subroto Paul; Paul C Lee; Jeffrey L Port; Paul J Christos; Brendon M Stiles; Nasser K Altorki
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-30       Impact factor: 5.209

4.  Long-term quality of life after Ivor Lewis esophagectomy for esophageal cancer.

Authors:  Silvio Däster; Savas D Soysal; Lea Stoll; Ralph Peterli; Markus von Flüe; Christoph Ackermann
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

5.  Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.

Authors:  Norma B Bulamu; Gang Chen; Julie Ratcliffe; Ann Schloite; Tim Bright; David I Watson
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

6.  The first randomised controlled trial on minimally invasive esophagectomy (MIE) and the ongoing quest for greater evidence.

Authors:  Marc M Dantoc; Michael R Cox; Guy D Eslick
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

7.  Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice.

Authors:  Sheraz R Markar; Melody Ni; Suzanne S Gisbertz; Leonie van der Werf; Jennifer Straatman; Donald van der Peet; Miguel A Cuesta; George B Hanna; Mark I van Berge Henegouwen
Journal:  J Clin Oncol       Date:  2020-05-18       Impact factor: 44.544

8.  Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival.

Authors:  Matthew Parsons; Shane Lloyd; Skyler Johnson; Courtney Scaife; Thomas Varghese; Robert Glasgow; Ignacio Garrido-Laguna; Randa Tao
Journal:  Ann Surg Oncol       Date:  2020-07-09       Impact factor: 5.344

Review 9.  ERAS and patient reported outcomes in thoracic surgery: a review of current data.

Authors:  Rachel L Medbery; Felix G Fernandez; Onkar V Khullar
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

10.  Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy.

Authors:  Kotaro Sugawara; Shuntaro Yoshimura; Koichi Yagi; Masato Nishida; Susumu Aikou; Yukinori Yamagata; Kazuhiko Mori; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.